AUTS2 Inhibitors

Chemical inhibitors of AUTS2 can exert their regulatory effects through distinct mechanisms, impacting the signaling pathways that are crucial for the protein's functional activity. For instance, LY294002 and Wortmannin are both PI3K inhibitors that can reduce phosphorylation of AKT, which in turn is pivotal for AUTS2 stability and function. This action can lead to a decrease in AUTS2's activity within the cell. Similarly, PD98059 and U0126, which are MEK inhibitors, can disrupt the MAPK/ERK pathway. Since this pathway is involved in synaptic plasticity where AUTS2 plays a role, its inhibition can lead to a reduction in the synaptic functions of AUTS2. SB203580, a p38 MAPK inhibitor, and SP600125, a JNK inhibitor, can prevent the activation of specific pathways that modulate the transcriptional coactivator functions of AUTS2, thus reducing its regulatory impact on gene expression. Rapamycin, as an mTOR inhibitor, can downregulate translational pathways, potentially reducing the expression of interacting or modulatory proteins of AUTS2, diminishing its activity.

Furthermore, Lactacystin, a proteasome inhibitor, can lead to an accumulation of misfolded proteins, indirectly affecting the level of functional AUTS2 through enhanced proteasomal degradation. Brefeldin A, by disrupting the Golgi apparatus function, can affect the post-translational processing of AUTS2, leading to its functional inhibition. Cyclosporin A, known to inhibit calcineurin, can also inhibit the dephosphorylation of nuclear factors that may interact with AUTS2, affecting its transcriptional coactivator functions. KN-93, as a CaMKII inhibitor, disrupts neuronal signaling pathways where AUTS2 is also implicated. By inhibiting these pathways, KN-93 can inhibit the functional role of AUTS2 within these contexts. Lastly, NF449, which selectively inhibits the Gαs subunit of G-proteins, can interrupt signaling pathways that regulate the activity and stability of various proteins, including AUTS2, leading to a decrease in the functional activity of AUTS2.